Correlation Between Neoleukin Therapeutics and Champions Oncology
Can any of the company-specific risk be diversified away by investing in both Neoleukin Therapeutics and Champions Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neoleukin Therapeutics and Champions Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neoleukin Therapeutics and Champions Oncology, you can compare the effects of market volatilities on Neoleukin Therapeutics and Champions Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neoleukin Therapeutics with a short position of Champions Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neoleukin Therapeutics and Champions Oncology.
Diversification Opportunities for Neoleukin Therapeutics and Champions Oncology
0.11 | Correlation Coefficient |
Average diversification
The 3 months correlation between Neoleukin and Champions is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding Neoleukin Therapeutics and Champions Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Champions Oncology and Neoleukin Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neoleukin Therapeutics are associated (or correlated) with Champions Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Champions Oncology has no effect on the direction of Neoleukin Therapeutics i.e., Neoleukin Therapeutics and Champions Oncology go up and down completely randomly.
Pair Corralation between Neoleukin Therapeutics and Champions Oncology
Given the investment horizon of 90 days Neoleukin Therapeutics is expected to generate 1.21 times more return on investment than Champions Oncology. However, Neoleukin Therapeutics is 1.21 times more volatile than Champions Oncology. It trades about 0.08 of its potential returns per unit of risk. Champions Oncology is currently generating about 0.0 per unit of risk. If you would invest 43.00 in Neoleukin Therapeutics on August 25, 2024 and sell it today you would earn a total of 26.00 from holding Neoleukin Therapeutics or generate 60.47% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 31.99% |
| Values | Daily Returns |
Neoleukin Therapeutics vs. Champions Oncology
Performance |
| Timeline |
| Neoleukin Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Champions Oncology |
Neoleukin Therapeutics and Champions Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Neoleukin Therapeutics and Champions Oncology
The main advantage of trading using opposite Neoleukin Therapeutics and Champions Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neoleukin Therapeutics position performs unexpectedly, Champions Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Champions Oncology will offset losses from the drop in Champions Oncology's long position.| Neoleukin Therapeutics vs. CytomX Therapeutics | Neoleukin Therapeutics vs. Spero Therapeutics | Neoleukin Therapeutics vs. Instil Bio | Neoleukin Therapeutics vs. NextCure |
| Champions Oncology vs. Molecular Partners AG | Champions Oncology vs. MediciNova | Champions Oncology vs. Anebulo Pharmaceuticals | Champions Oncology vs. Shattuck Labs |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Complementary Tools
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |